Evidence map›Paper›PMID 10945032›Full record

ReviewSpringer seminars in immunopathology1999

Fibroblast heterogeneity in physiological conditions and fibrotic disease.

A Jelaska, D Strehlow, J H Korn

Abstract readReview
PubMed
In one paragraph

Review in Springer seminars in immunopathology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Transcriptomics ofMicroorganisms · 2024
    Article
  2. Identification of Periostin as a critical niche for myofibroblast dynamics and fibrosis during tendon healing.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Molecular and cellular basis of scleroderma.Journal of molecular medicine (Berlin, Germany) · 2014
    Review
  7. Review
  8. MicroRNAs in pulmonary arterial remodeling.Cellular and molecular life sciences : CMLS · 2013
    Review
  9. Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2013
    Article
  10. Review
  11. Mannose receptor 2 attenuates renal fibrosis.Journal of the American Society of Nephrology : JASN · 2012
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Gene targeting to the stroma of the prostate and bone.Differentiation; research in biological diversity · 2008
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

A JelaskaArthritis Center, Boston University School of Medicine, MA 02118, USA.
D Strehlow
J H Korn

Funding

IMMUNE MEDIATED ALTERATIONS IN CONNECTIVE TISSUE CELLSR01AR032343 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KORN, JOSEPH H · 1986 to 2000
$300k
NIAMS NIH HHS AR 32343
6 · The paper itself

Abstract

Inflammation and tissue injury are strong stimuli for fibroblast activation and initiation of reparative processes. In certain disease states, pathological fibrosis occurs. Fibroblasts isolated from these diseased tissues often display a persistently abnormal phenotype characterized by increased synthesis of matrix components such as collagen. This metabolic abnormality is apparently independent of continued exposure to any pathological stimulus that may have initiated the process. Since fibroblasts are heterogeneous in proliferative capacity, in synthesis of collagen and other matrix proteins and in response to immune mediators and growth factors, clonal selection, i.e. selective increase in fibroblast subpopulations, may explain the long-term effects of acute in vivo activation on fibroblast behavior. Studies of SSc fibroblasts are consistent with clonal selection and/or clonal activation, processes that may play an important role in fibrosis in this and other disorders.

Indexed as

AnimalsCell DifferentiationCell DivisionConnective Tissue DiseasesFibroblastsFibrosisHumans

Identifiers

PMID10945032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.